Edition:
United Kingdom

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.12CNY
14 Dec 2017
Change (% chg)

¥0.01 (+0.14%)
Prev Close
¥7.11
Open
¥7.08
Day's High
¥7.15
Day's Low
¥7.08
Volume
6,059,592
Avg. Vol
13,273,824
52-wk High
¥8.00
52-wk Low
¥6.42

Chart for

About

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.94
Market Cap(Mil.): ¥17,750.86
Shares Outstanding(Mil.): 2,510.73
Dividend: 0.12
Yield (%): 1.70

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Zhejiang CONBA Pharmaceutical's 9-month net profit up 34.9 pct y/y

* Says 9-month net profit up 34.9 percent y/y at 607.1 million yuan ($91.74 million)

17 Oct 2017

BRIEF-Zhejiang Conba Pharmaceutical gets approval to issue 1.5 bln yuan medium-term notes

* Says it gets approval to issue 1.5 billion yuan ($228.81 million) medium-term notes

18 Sep 2017

BRIEF-Jinyuan Cement issues 119.4 mln shares and raises 1.21 bln yuan through private placement

* Says it issued 119.4 million shares and raised 1.21 billion yuan through private placement

18 Aug 2017

BRIEF-Zhejiang Conba Pharmaceutical's H1 net profit up 25.2 pct y/y

* Says H1 net profit up 25.2 percent y/y at 384.6 million yuan ($57.66 million)

14 Aug 2017

BRIEF-Zhejiang CONBA Pharmaceutical unit received approval for drug clinical trials

* Says its controlling unit has been granted approval for drug clinical trials for pirfenidone tablets issued by china food and drug administration

27 Jul 2017

BRIEF-Zhejiang CONBA Pharma's prelim H1 profit up 25.3 pct y/y

* Says preliminary H1 net profit up 25.3 percent y/y at 384.9 million yuan ($56.61 million)

11 Jul 2017

BRIEF-Zhejiang Conba Pharmaceutical's controlling shareholder to add up to 2 pct stake in next 6 months

* Says its controlling shareholder plans to add up to 2 percent stake in next 6 months

19 Jun 2017

Earnings vs. Estimates